Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Modulating cardiac myosin heavy chain isoform expression for treating cardiomyopathies

  • Post author:
  • Post published:March 18, 2026
  • Post category:

Research Objective To discover CRISPR-based genetic strategies that will directly and therapeutically modify cardiac myosin heavy chain isoform expression to treat HF and cardiomyopathies. Impact Heart Failure and Cardiomyopathies Major…

Continue ReadingModulating cardiac myosin heavy chain isoform expression for treating cardiomyopathies

Development of a VAV2 antisense oligonucleotide (ASO) treatment for ALS

  • Post author:
  • Post published:March 18, 2026
  • Post category:

Research Objective Patient specific stem cells (iPSCs) to model ALS and identify a broadly acting therapeutic intervention Impact Heterogenous patient population, dire need for broadly acting therapeutic interventions Major Proposed…

Continue ReadingDevelopment of a VAV2 antisense oligonucleotide (ASO) treatment for ALS

C9orf72 repeat expansion-tuned allelic suppression by CRISPRi as an ALS therapy

  • Post author:
  • Post published:March 18, 2026
  • Post category:

Research Objective We aim to discover an adeno-associated viral (AAV) CRISPRi gene therapy for amyotrophic lateral sclerosis (ALS) patients with hexanucleotide repeat expansions in the C9orf72 gene. Impact This therapy…

Continue ReadingC9orf72 repeat expansion-tuned allelic suppression by CRISPRi as an ALS therapy

Treatment of Myasthenic Syndrome due to Choline Acetyltransferase Deficiency Using AAV9-mediated Gene Therapy

  • Post author:
  • Post published:March 18, 2026
  • Post category:

Research Objective Use of a viral vector to transport a normal gene to children with severe motor and respiratory disabilities caused by an inborn defect of the choline acetyltransferase (ChAT)…

Continue ReadingTreatment of Myasthenic Syndrome due to Choline Acetyltransferase Deficiency Using AAV9-mediated Gene Therapy

Development of an Optogenetic Vision Restoration Gene Therapy Using an Engineered Form of Melanopsin

  • Post author:
  • Post published:March 18, 2026
  • Post category:

Research Objective The objective of this research proposal is to develop a lead AAV candidate for an optogenetic vision restoration therapy for patients suffering from blindness due to loss of…

Continue ReadingDevelopment of an Optogenetic Vision Restoration Gene Therapy Using an Engineered Form of Melanopsin

RNA-based therapeutics to augment regulatory T cells: a novel approach to treat myocarditis

  • Post author:
  • Post published:March 18, 2026
  • Post category:

Research Objective Use human cell therapy insights, specifically CDC-secreted EV analysis, to develop a noncoding RNA chemical entity for myocarditis treatment. Impact Key knowledge gap is how to recruit adaptive…

Continue ReadingRNA-based therapeutics to augment regulatory T cells: a novel approach to treat myocarditis

In Utero Treatment of Duchenne Muscular Dystrophy with Non-viral Gene Editing

  • Post author:
  • Post published:March 18, 2026
  • Post category:

Research Objective To develop a lipid nanoparticle/mRNA complex that can safely and efficiently edit muscle stem cells in utero, correct the dystrophin mutation, and develop a treatment for Duchenne muscular…

Continue ReadingIn Utero Treatment of Duchenne Muscular Dystrophy with Non-viral Gene Editing

Gene Therapy for SLC6A8 Creatine Transporter Disorder

  • Post author:
  • Post published:March 18, 2026
  • Post category:

Research Objective The objective is to define a final therapeutic candidate for an effective gene therapy for mutations of the creatine transporter SLC6A8, a major cause of X-linked intellectual disability…

Continue ReadingGene Therapy for SLC6A8 Creatine Transporter Disorder

Novel Lipid Nanoparticles for Enhancing eNOS Synthesis for Cardioprotection Post Myocardial Infarction

  • Post author:
  • Post published:March 18, 2026
  • Post category:

Research Objective Our therapeutic candidate is a lipid nanoparticle that delivers a therapeutic dose of mRNA to the human heart, which transiently transfects of cells within the heart to improve…

Continue ReadingNovel Lipid Nanoparticles for Enhancing eNOS Synthesis for Cardioprotection Post Myocardial Infarction

Modified RNA-Based Gene Therapy for Cardiac Regeneration Through Cardiomyocyte Proliferation

  • Post author:
  • Post published:March 18, 2026
  • Post category:

Research Objective Efficacious and safe intramyocardial delivery of modified mRNA encoding cell cycle regulators as a gene therapy for cardiac regeneration through resident cardiomyocyte proliferation. Impact This project would provide…

Continue ReadingModified RNA-Based Gene Therapy for Cardiac Regeneration Through Cardiomyocyte Proliferation
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 8
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us